Show all Uncategorized Medical News February 10, 2022First Biotech to complete a Phase III for Long Hauler COVID-19 symptomsby Emphycorp November 7, 2021 Study evaluates treatment of ‘long COVID’ patientsby Emphycorp November 7, 2021N115 Nasal Spray Found to Improve Lung Function in PF Patientsby Emphycorp November 7, 2021EmphyCorp Inc. Non-Steroidal N115 Nasal Spray Completed Phase III Clinical Trial for COVID-19, Long COVID-19 (Long Haulers), and Pulmonary Fibrosisby Emphycorp November 7, 2021European Journal of Respiratory Medicine Peer Reviewed Publication – “Inhalation of Sodium Pyruvate to Reduce the Symptoms and Severity of Respiratory Diseases Including COVID-19, Long COVID, and Pulmonary Fibrosisby Emphycorp October 18, 2021The Market of Emphycorpby Emphycorp October 18, 2021Emphycorp Proprietary N115by Emphycorp October 18, 2021New Non-Steroidal Treatment for Pulmonary Fibrosisby Emphycorp
